73 research outputs found

    J. S. Bach English Suites No. 3 BWV 808, R. Schumann Intermezzi Op. 4, L. v. Beethoven Piano Sonata No. 23, Op. 57 ์—ฐ๊ตฌ

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ (์„์‚ฌ)-- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› ์Œ์•…๋Œ€ํ•™ ์Œ์•…๊ณผ, 2017. 8. ์žฅํ˜•์ค€.๋ณธ ์—ฐ๊ตฌ๋Š” ๋ณธ์ธ์˜ ์„์‚ฌ๊ณผ์ • ์กธ์—…์—ฐ์ฃผ ํ”„๋กœ๊ทธ๋žจ์ธ J. S. Bach์˜ English Suites No.3 in g minor, BWV 808๊ณผ R. Schumann์˜ Intermezzi Op.4, ๋งˆ์ง€๋ง‰์œผ๋กœ L. v. Beethoven Piano Sonata No.23 in f minor, Op.57์— ์žˆ์–ด ๊ฐ ์ž‘๊ณก๊ฐ€์™€ ๊ณก์˜ ๋ฐฐ๊ฒฝ, ๊ณก์˜ ํŠน์ง•์„ ์•Œ์•„๋ณด๊ณ  ๊ณก์— ๋Œ€ํ•œ ์ดํ•ด๋ฅผ ๋†’์ด๊ณ ์ž ํ•œ๋‹ค. ์ฒซ ๋ฒˆ์งธ๋กœ J. S. Bach (1685-1750)์˜ English Suites, ์˜๊ตญ ์กฐ๊ณก 3๋ฒˆ์„ ์ดํ•ดํ•˜๊ธฐ ์œ„ํ•ด์„œ ๋ฐ”๋กœํฌ ์Œ์•…๊ณผ Bach์˜ ๊ฑด๋ฐ˜์Œ์•…, ์˜๊ตญ ์กฐ๊ณก์˜ ๊ตฌ์„ฑ๊ณผ ํŠน์ง•, ๋” ์ž์„ธํ•˜๊ฒŒ๋Š” ์˜๊ตญ ์กฐ๊ณก 3๋ฒˆ์— ๋Œ€ํ•˜์—ฌ ๊ณ ์ฐฐ ํ•  ๊ฒƒ์ด๋‹ค. ๋‘ ๋ฒˆ์งธ๋กœ R. Schumann (1810-1856)์˜ Intermezzi Op.4๋ฅผ ์œ„ํ•ด์„œ๋Š” ์Šˆ๋งŒ์ด ์†ํ•ด์žˆ๋Š” ๋‚ญ๋งŒ์ฃผ์˜ ์Œ์•…์˜ ์ „์ฒด์ ์ธ ํŠน์ง•์„ ์‚ดํŽด๋ณด๊ณ  Schumann์˜ ํ”ผ์•„๋…ธ ์Œ์•… ํŠน์ง•๊ณผ Intermezzo์˜ ๊ธฐ์› ๋ฐ ๋ฐฐ๊ฒฝ, ํŠน์ง•์— ๋Œ€ํ•ด ์—ฐ๊ตฌํ•  ๊ฒƒ์ด๋‹ค. ๋งˆ์ง€๋ง‰์œผ๋กœ L. v. Beethoven (1770-1827)์˜ Piano Sonata No.23์„ ์—ฐ๊ตฌํ•จ์— ์žˆ์–ด์„œ๋Š” Beethoven์˜ ํ”ผ์•„๋…ธ ์Œ์•…๊ณผ ํ”ผ์•„๋…ธ ์†Œ๋‚˜ํƒ€์— ๋Œ€ํ•˜์—ฌ ์•Œ์•„๋ณด๊ณ , ์—ด์ • ์†Œ๋‚˜ํƒ€๋ฅผ ํ†ตํ•ด ๊ณ ์ „์กฐ์˜ ์Œ์•…์„ ๋‚ญ๋งŒ์ฃผ์˜ ์Œ์•…์œผ๋กœ ๋ฐœ์ „์‹œํ‚จ Beethoven์˜ ์Œ์•…์  ํ‘œํ˜„๋“ค์„ ์‚ดํŽด๋ณผ ๊ฒƒ์ด๋‹ค. ์ด๋กœ์จ ๋ณธ ์—ฐ๊ตฌ๋Š” ์—ฐ์ฃผ์ž๋กœ์„œ ์ž‘๊ณก๊ฐ€๊ฐ€ ํ‘œํ˜„ํ•˜๊ณ ์ž ํ•˜๋Š” ๋‚ด์šฉ๊ณผ ๊ฐ์ •์„ ์˜ฌ๋ฐ”๋ฅด๊ฒŒ ์ดํ•ดํ•˜์—ฌ ์‹ค์ œ ์—ฐ์ฃผ์— ์žˆ์–ด ๋„์›€์ด ๋˜๊ณ ์ž ํ•œ๋‹ค.I. ์„œ๋ก  1 II. ๋ณธ ๋ก  3 1. J. S. Bach English Suites No. 3, BWV 808 3 1) ์ž‘ํ’ˆ๋ฐฐ๊ฒฝ 3 2) ์ž‘ํ’ˆ๋ถ„์„ 4 2. R. Schumann Intermezzi Op.4 22 1) ์ž‘ํ’ˆ๋ฐฐ๊ฒฝ 22 2) ์ž‘ํ’ˆ๋ถ„์„ 23 3. L.v. Beethoven Piano Sonata No.23, Op.57 32 1) ์ž‘ํ’ˆ๋ฐฐ๊ฒฝ 32 2) ์ž‘ํ’ˆ๋ถ„์„ 33 III. ๊ฒฐ ๋ก  43 IV. ์ฐธ๊ณ ๋ฌธํ—Œ 45 V. Abstract 46Maste

    ๊ณต๊ณต๋ถ€๋ฌธ์˜ ํŒ€์ œ์™€ ์„ฑ๊ณผ๊ด€๋ฆฌ

    No full text
    2005๋…„ ์šฐ๋ฆฌ๋‚˜๋ผ์˜ ๊ณต๊ณต๋ถ€๋ฌธ์— ํŒ€์ œ๊ฐ€ ๋ณธ๊ฒฉ์ ์œผ๋กœ ๋„์ž…๋˜์—ˆ๋‹ค. ํŒ€์ œ๊ฐ€ ์„ฑ๊ณต์ ์œผ๋กœ ์ •์ฐฉ๋˜๋ ค๋ฉด ์ ์ ˆํ•œ ์ธ์„ผํ‹ฐ๋ธŒ ์ œ๋„๊ฐ€ ๋’ท๋ฐ›์นจ๋˜์–ด์•ผ ํ•œ๋‹ค. ๊ทธ๋Ÿฌ๋‚˜ ๊ณต๊ณต๋ถ€๋ฌธ์˜ ํŒ€์ œ๋„์ž…์— ๋”ฐ๋ฅธ ์ธ์„ผํ‹ฐ๋ธŒ ์ œ๋„์˜ ์„ค๊ณ„์— ๊ด€ํ•œ ์—ฐ๊ตฌ๋Š” ์ฐพ์•„๋ณด๊ธฐ ํž˜๋“  ๊ฒƒ์ด ์‚ฌ์‹ค์ด๋‹ค. ์ด ์—ฐ๊ตฌ๋Š” ์ด๋Ÿฌํ•œ ์ธ์‹์„ ๋ฐ”ํƒ•์œผ๋กœ ์ธ์„ผํ‹ฐ๋ธŒ ์ œ๋„์˜ ๊ทผ๊ฐ„์„ ์ด๋ฃจ๋Š” ๊ธฐ๋ณธ๋ชจํ˜•์— ๋Œ€ํ•ด ๊ณ ์ฐฐํ•˜๊ณ , ๊ณต๊ณต๋ถ€๋ฌธ์˜ ํŠน์ˆ˜ํ•œ ์ƒํ™ฉ์— ๋Œ€ํ•ด์„œ๋„ ์‚ดํŽด๋ณด๊ณ ์ž ํ•œ๋‹ค. ์ด๋Ÿฌํ•œ ๋…ผ์˜๋ฅผ ๋ฐ”ํƒ•์œผ๋กœ ํŒ€์ œ์—์„œ ์ธ์„ผํ‹ฐ๋ธŒ ์ œ๋„์„ค๊ณ„์™€ ๊ด€๋ จ๋œ ์ฃผ์š” ์Ÿ์ ์ธ ๊ฐœ์ธํ‰๊ฐ€์™€ ์ง‘๋‹จํ‰๊ฐ€, ์‹ค์ ํ‰๊ฐ€์™€ ํ–‰ํƒœํ‰๊ฐ€, ํ‰๊ฐ€๊ฒฐ๊ณผ์˜ ๋ถ„ํฌ์„ค์ • ๋“ฑ์— ๋Œ€ํ•ด ์‹œ์‚ฌ์ ์„ ๋„์ถœํ•œ๋‹ค. ๋˜ํ•œ ํŒ€์ œ๋ฅผ ๋„์ž…ํ•˜์—ฌ ์‚ฌ์šฉํ•˜๊ณ  ์žˆ๋Š” ๋ถ€์ฒ˜๋“ค์˜ ํ˜„ํ™ฉ์„ ์œ„์˜ ์„ธ ๊ฐ€์ง€ ์Ÿ์ ์„ ์ค‘์‹ฌ์œผ๋กœ ์‚ดํŽด๋ณด๊ณ  ํ‰๊ฐ€ํ•œ๋‹ค. ์ด ์—ฐ๊ตฌ์˜ ์ฃผ์š” ์‹œ์‚ฌ์ ์„ ์š”์•ฝํ•˜๋ฉด, ๋จผ์ € ํ‰๊ฐ€๋Š” ์ง‘๋‹จํ‰๊ฐ€๋ฅผ ์œ„์ฃผ๋กœ ํ•˜๋˜ ํŒ€์˜ ํฌ๊ธฐ์— ๋”ฐ๋ผ ๋‹ฌ๋ผ์ ธ์•ผ ํ•œ๋‹ค๋Š” ์ ์„ ๋“ค ์ˆ˜ ์žˆ๋‹ค. ๋˜ํ•œ ์‹ค์ ํ‰๊ฐ€๋ฅผ ์œ„์ฃผ๋กœ ํ•˜๋˜ ์‹ค์ ์˜ ๊ด€์ฐฐ๊ฐ€๋Šฅ์„ฑ, ์‹ค์ ํ‰๊ฐ€๊ฐ€ ํ‰๊ฐ€๋Œ€์ƒ์„ ํฌํ•จํ•  ์ˆ˜ ์žˆ๋Š” ์ •๋„ ๋“ฑ์— ๋”ฐ๋ผ ์‹ค์ ํ‰๊ฐ€์™€ ํ–‰ํƒœํ‰๊ฐ€์˜ ๋น„์ค‘์ด ์ ์ ˆํžˆ ๋ฐฐํ•ฉ๋˜์–ด์•ผ ํ•œ๋‹ค. ํ•œํŽธ ํŒ€์›๊ฐ„์˜ ํ‰๊ฐ€๊ฒฐ๊ณผ๋Š” ์ฐจ์ด๊ฐ€ ํฌ์ง€ ์•Š๋„๋ก ํ•˜๊ณ  ํŒ€๊ฐ„์˜ ํ‰๊ฐ€๊ฒฐ๊ณผ๋Š” ์ƒ๋‹นํ•œ ์ฐจ์ด๊ฐ€ ๋‚˜๋„๋ก ํ•˜๋Š” ๊ฒƒ์ด ๋ฐ”๋žŒ์งํ•˜๋‹ค

    ํ˜•์ƒ๊ธฐ์–ตํ•ฉ๊ธˆ๊ณผ ์ด๋ฅผ ์ด์šฉํ•œ ์ง€๋Šฅ๊ตฌ์กฐ๋ฌผ์˜ ํŠน์„ฑ์— ๊ด€ํ•œ ์—ฐ๊ตฌ

    No full text
    Thesis(doctors) --์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :๊ธฐ๊ณ„ํ•ญ๊ณต๊ณตํ•™๋ถ€,2008.8.Docto

    Efficacy of the HLA-B*58:01 Screening Test in Preventing Allopurinol-Induced Severe Cutaneous Adverse Reactions in Patients with Chronic Renal Insufficiency-A Prospective Study

    No full text
    BACKGROUND: Thus far, human leukocyte antigen (HLA)-B*58:01 has been recognized as the most important risk factor for allopurinol induced severe cutaneous adverse reactions (SCARs). OBJECTIVE: To determine the usefulness of prospective screening for the HLA-B*58:01 allele to identify Korean individuals at risk for SCARs induced by allopurinol treatment. METHODS: We prospectively enrolled 542 patients with chronic renal insufficiency (CRI) from 10 hospitals nationwide and performed DNA genotyping to determine whether they carried the HLA-B*58:01 allele. Of these, 503 HLA-B*58:01-negative patients (92.8% of total) were treated with allopurinol, and 39 HLA-B*58:01-positive patients (7.2%) were treated with febuxostat, an alternative drug. The patients then were followed up biweekly for 90 days using a telephone survey to monitor symptoms of adverse drug reactions, including SCARs. As a control, we used the historical incidence rate of allopurinol-induced SCARs in 4002 patients with CRI from the same hospitals who were enrolled retrospectively. RESULTS: Nineteen patients in the prospective cohort developed mild and transient adverse reactions but none showed allopurinol-induced SCARs. By contrast, we identified 38 patients with allopurinol-induced SCARs (0.95%) in the historical control. The difference in the incidence of allopurinol-induced SCARs between the prospective cohort and historical control was statistically significant (0% vs 0.95%, respectively; P = .029). CONCLUSIONS: The present study demonstrated the clinical usefulness of the HLA-B*58:01 screening test before allopurinol administration to prevent allopurinol-induced SCARs in patients with CRI. (C) 2018 American Academy of Allergy, Asthma & ImmunologyThis research was supported by a grant (15182MFDS506) from Ministry of Food and Drug Safety in 2016 and 2017

    KAAACI Standardization Committee report on the procedure and application of induced sputum examination

    No full text
    Induced sputum and sputum cell count analysis is a test for the diagnosis of various respiratory diseases. In particular, it has long been used as an important biomarker in the diagnosis or characterization of asthma or eosinophilic bronchitis. Despite a relatively long history of this test, there has been no consensus report for conducting and interpreting the analyses in Korea. Based on this awareness and necessity, the Korean Academy of Asthma, Allergy and Clinical Immunology launched the Standardization Committee to review the international guidelines and the literature and to develop a consensus report on the diagnostic procedure and interpretation of the sputum induction testThis research was supported by a fund (A092076) by Research of Korea Centers for Disease Control and Prevention

    WTO ้ซ”ๅˆถไธ‹์—์„œ ่ผธๅ‡บๆ”ฏๆด๏คŠ่žๅˆถๅบฆ์— ๊ด€ํ•œ ็ก็ฉถ

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธๅคงๅญธๆ ก ่กŒๆ”ฟๅคงๅญธ้™ข :่กŒๆ”ฟๅญธ็ง‘ ๆ”ฟ็ญ–ๅญธๅฐˆๆ”ป,1996.Maste

    Regulation and Economic Growth: An Empirical Analysis Based on Regulation Theories

    No full text
    ๊ทœ์ œ๊ฐ€ ๊ฒฝ์ œ์— ๋ฏธ์น˜๋Š” ํšจ๊ณผ์™€ ๊ด€๋ จ๋œ ๊ธฐ์กด์˜ ์—ฐ๊ตฌ๋“ค์€ ์ผ์น˜๋œ ๊ฒฐ๊ณผ๋ฅผ ๋ณด์ด์ง€ ์•Š๊ณ  ์žˆ๋‹ค. ๋˜ํ•œ ์ด๋“ค์€ ์ด๋ก ์ ์ธ ๋ฐฐ๊ฒฝ์— ๊ธฐ์ดˆ๋ฅผ ๋‘๊ณ  ์žˆ์ง€ ์•Š๋‹ค๋Š” ๊ณตํ†ต์ ์ธ ํ•œ๊ณ„๋ฅผ ๊ฐ€์ง€๊ณ  ์žˆ๋‹ค. ์ด์™€ ๊ฐ™์€ ํ•œ๊ณ„๋ฅผ ๊ทน๋ณตํ•˜๊ณ ์ž ๋ณด๋‹ค ์ด๋ก ์ ์ธ ๋ฐฐ๊ฒฝ์—์„œ ์‹ค์ฆ๋ถ„์„ ๋ชจํ˜•์„ ๋„์ถœํ•˜๊ณ  ์ถ”์ •ํ•˜์˜€๋‹ค. ๊ทธ ๊ฒฐ๊ณผ, ๊ทœ์ œ๊ฐ€ ๊ฒฝ์ œ์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ์€ ์ผ๋ฅ ์ ์œผ๋กœ ๊ฒฐ์ •๋˜์ง€ ์•Š์œผ๋ฉฐ ์ด์ต์ง‘๋‹จ์˜ ํ™œ์„ฑํ™” ์ •๋„์— ๋”ฐ๋ผ ๋‹ฌ๋ผ์ง„๋‹ค๋Š” ๊ฒƒ์„ ๋ฐœ๊ฒฌํ•˜์˜€๋‹ค. ์ฆ‰ ์ด์ต์ง‘๋‹จ์˜ ํ™œ์„ฑํ™” ์ •๋„๊ฐ€ ๊ทœ์ œ์˜ ๊ฒฝ์ œ์— ๋Œ€ํ•œ ์˜ํ–ฅ๋ ฅ์„ ์กฐ์ ˆํ•˜๋Š” ๋ณ€์ˆ˜๋กœ์„œ ์—ญํ• ์„ ํ•˜๊ฒŒ ๋œ๋‹ค๋Š” ๊ฒƒ์„ ์•Œ ์ˆ˜ ์žˆ์—ˆ๋‹ค. ์ •๋ถ€์˜ ๊ฒฝ์ œ์ •์ฑ…์ด ์ด์ต์ง‘๋‹จ์˜ ์••๋ ฅ์œผ๋กœ๋ถ€ํ„ฐ ๋…๋ฆฝ์ ์œผ๋กœ ์ˆ˜ํ–‰๋˜๋Š” ์ •๋„๊ฐ€ ๊ฐ•ํ•œ ๊ฒฝ์šฐ(์ด์ต์ง‘๋‹จ์˜ ์˜ํ–ฅ๋ ฅ์ด ์ƒ๋Œ€์ ์œผ๋กœ ์•ฝํ•œ ๊ฒฝ์šฐ) ์ž์œ ๋„๊ฐ€ ์ปค์งˆ์ˆ˜๋ก, ํ–‰์ •๊ทœ์ œ๊ฐ€ ์•ฝํ• ์ˆ˜๋ก, ์‚ฌ๊ฒฝ์ œ๋ฅผ ์ด‰์ง„ํ•˜๋Š” ์ •์ฑ…๊ณผ ๊ทœ์ œ๊ฐ€ ์ปค์งˆ์ˆ˜๋ก ๊ฒฝ์ œ์„ฑ์žฅ๋ฅ ์€ ๋†’์•„์ง„๋‹ค. ๋ฐ˜๋ฉด, ์ด์ต์ง‘๋‹จ์˜ ์˜ํ–ฅ๋ ฅ์ด ์ƒ๋Œ€์ ์œผ๋กœ ๊ฐ•ํ•œ ๊ฒฝ์šฐ์—๋Š” ์ž์œ ๋„๊ฐ€ ์ปค์งˆ์ˆ˜๋ก, ํ–‰์ •๊ทœ์ œ๊ฐ€ ์•ฝํ• ์ˆ˜๋ก, ์‚ฌ๊ฒฝ์ œ๋ฅผ ์ด‰์ง„ํ•˜๋Š” ์ •์ฑ…๊ณผ ๊ทœ์ œ๊ฐ€ ์ปค์งˆ์ˆ˜๋ก ๊ฒฝ์ œ์„ฑ์žฅ๋ฅ ์€ ๋‚ฎ์•„์ง€๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ๋‹ค. There has not been general agreement in academia over the relationship between government regulation and economic growth. Previous studies share a limit in that their analyses do not stand on theoretical grounds. This paper aims to overcome this limit of previous studies by deriving empirical models from regulation theories and estimating the relationship based on the models. The empirical results show that the effects of regulation on economic growth are dependent on the degree of interest group activities. In other words, interest groups play the role of a moderating variable. Government regulation contributes to economic growth when economic policies are decided and implemented independently from the influence of interest groups. In contrast, regulation slows economic growth where interest groups are active and strong.๋ณธ ์—ฐ๊ตฌ๋Š” 2008๋…„ ์ •๋ถ€์žฌ์›(๊ต์œก์ธ์ ์ž์›๋ถ€ ํ•™์ˆ ์—ฐ๊ตฌ์กฐ์„ฑ์‚ฌ์—…๋น„ ์‹ ์ง„์—ฐ๊ตฌ์ง€์›)์œผ๋กœ ํ•œ๊ตญํ•™์ˆ ์ง„ํฅ์žฌ๋‹จ์˜ ์ง€์›์„ ๋ฐ›์•„ ์—ฐ๊ตฌ๋˜์—ˆ์Œ(KRF-2008-327-B00749)

    KAAACI Evidence-Based Clinical Practice Guidelines for Chronic Cough in Adults and Children in Korea

    No full text
    Chronic cough is common in the community and causes significant morbidity. Several factors may underlie this problem, but comorbid conditions located at sensory nerve endings that regulate the cough reflex, including rhinitis, rhinosinusitis, asthma, eosinophilic bronchitis, and gastroesophageal reflux disease, are considered important. However, chronic cough is frequently non-specific and accompanied by not easily identifiable causes during the initial evaluation. Therefore, there are unmet needs for developing empirical treatment and practical diagnostic approaches that can be applied in primary clinics. Meanwhile, in referral clinics, a considerable proportion of adult patients with chronic cough are unexplained or refractory to conventional treatment. The present clinical practice guidelines aim to address major clinical questions regarding empirical treatment, practical diagnostic tools for nonspecific chronic cough, and available therapeutic options for chronic wet cough in children and unexplained chronic cough in adults in Korea.This guideline for chronic cough was developed with the support of the Korean Academy of Asthma, Allergy and Clinical Immunology
    • โ€ฆ
    corecore